Alligator Bioscience Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Søren Bregenholt
Chief executive officer
SEK 4.4m
Total compensation
CEO salary percentage | 72.8% |
CEO tenure | 2yrs |
CEO ownership | 0.00004% |
Management average tenure | 2yrs |
Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -SEK 213m |
Dec 31 2022 | SEK 4m | SEK 3m | -SEK 193m |
Sep 30 2022 | n/a | n/a | -SEK 177m |
Jun 30 2022 | n/a | n/a | -SEK 163m |
Mar 31 2022 | n/a | n/a | -SEK 152m |
Dec 31 2021 | SEK 4m | SEK 2m | -SEK 142m |
Compensation vs Market: Søren's total compensation ($USD409.61K) is about average for companies of similar size in the UK market ($USD348.41K).
Compensation vs Earnings: Søren's compensation has increased whilst the company is unprofitable.
CEO
Søren Bregenholt (52 yo)
2yrs
Tenure
SEK 4,400,000
Compensation
Mr. Søren Bregenholt, Ph D serves as the Chief Executive Officer at Alligator Bioscience AB (publ) since June 01, 2021. He served as the Chief Operating Officer of Symphogen A/S.Mr. Bregenholt served as S...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 2yrs | SEK 4.40m | 0.000040% SEK 153.9 | |
Chief Financial Officer | 2.8yrs | no data | 0.0096% SEK 37.0k | |
Head of R&D | 3.4yrs | SEK 568.00k | 0.0016% SEK 6.2k | |
Chief Technology Officer | less than a year | no data | 0.00042% SEK 1.6k | |
Chief Scientific Officer | 2.4yrs | no data | 0.0064% SEK 24.7k | |
Director of Communications & Investor Relations | 1.8yrs | no data | no data | |
Chief Medical Officer | 1.3yrs | no data | no data |
2.0yrs
Average Tenure
52yo
Average Age
Experienced Management: ATORXS's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 1.1yrs | SEK 200.00k | no data | |
Independent Chairman of the Board | 6.1yrs | SEK 696.00k | 0.015% SEK 57.5k | |
Independent Director | 2yrs | SEK 381.00k | no data | |
Independent Vice Chairman of the Board | 2yrs | SEK 569.00k | 0.11% SEK 431.9k | |
Independent Director | 1.1yrs | SEK 217.00k | no data | |
Independent Director | 2yrs | SEK 371.00k | 0.0050% SEK 19.3k | |
Independent Director | 4.1yrs | SEK 342.00k | no data |
2.0yrs
Average Tenure
62yo
Average Age
Experienced Board: ATORXS's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/06/19 10:21 |
End of Day Share Price | 2023/03/22 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alligator Bioscience AB (publ) is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ingrid Gafanhão | Kempen & Co. NV |
Carl Ramanius | Redeye |